• Explore /
  • Poster
  • / Impact of PD-L1 expression on survival in patients with unresectable/recurrent gastric cancer receiving first-line chemotherapy without immune checkpoint inhibitors.

Impact of PD-L1 expression on survival in patients with unresectable/recurrent gastric cancer receiving first-line chemotherapy without immune checkpoint inhibitors.

Abstract Poster

Authors

null

Hidekazu Hirano

National Cancer Center Hospital, Tokyo, Japan

Hidekazu Hirano , Yasuhide Yamada , Kengo Nagashima , Nobuyoshi Hiraoka , Shigeki Sekine , Naoki Takahashi , Mizutomo Azuma , Satoru Iwasa , Keisuke Kanato , Nozomu Machida , Takahiro Kinoshita , Hiroaki Hata , Hisato Kawakami , Daisuke Takahari , Toshiyasu Ojima , Shigenori Kadowaki , Narikazu Boku , Yukinori Kurokawa , Masanori Terashima , Takaki Yoshikawa

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Clinical Trial Registration Number

UMIN000007652

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 391)

DOI

10.1200/JCO.2024.42.3_suppl.391

Abstract #

391

Poster Bd #

J14

Abstract Disclosures

Similar Posters

First Author: Kohei Shitara

First Author: Lin Shen

First Author: Yelena Y. Janjigian

First Author: Lin Shen